Discontinued — last reported Q1 '26
Zimmer Biomet Holdings Net Income increased by 70.9% to $238.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.8%, from $182.00M to $238.10M. Over 2 years (FY 2023 to FY 2025), Net Income shows a downward trend with a -17.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
The most common metric for evaluating company performance against industry competitors.
net_income| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $141.90M | $145.60M | $14.20M | $153.70M | $194.00M | $232.50M | $209.60M | $162.70M | $419.20M | $172.40M | $242.80M | $249.10M | $239.50M | $182.00M | $152.80M | $230.90M | $139.30M | $238.10M |
| QoQ Change | — | +2.6% | -90.2% | +982.4% | +26.2% | +19.8% | -9.8% | -22.4% | +157.7% | -58.9% | +40.8% | +2.6% | -3.9% | -24.0% | -16.0% | +51.1% | -39.7% | +70.9% |
| YoY Change | — | — | — | +8.3% | +33.2% | >999% | +36.4% | -16.1% | — | -25.8% | +15.8% | +53.1% | -42.9% | +5.6% | -37.1% | -7.3% | -41.8% | +30.8% |